Elevated Cerebrospinal Fluid α‐Synuclein Seeding Activity Predicts Central Lewy Body Diseases
Movement Disorders Clinical Practice · 2025
DOI: 10.1002/mdc3.14333 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, 2025. Verfasst von David S Goldstein und 6 weiteren Autor:innen. Beteiligte Einrichtung: Autonomic Medicine Section (AMS), Clinical Neurosciences Program (CNP), Division of Intramural Research (DIR), National Institute of Neurological Dis…. Hauptthemen laut MEDLINE: Lewy Body Disease, alpha-Synuclein. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, National Institute of Allergy and Infectious Diseases, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Background
Cerebrospinal fluid (CSF) α‐synuclein seeding activity (SSA) via a seed amplification assay might predict central Lewy body diseases (LBD) in at‐risk individuals.
Objective
The aim was to assess CSF SSA in a prospective, longitudinal study.
Methods
Participants self‐reported risk factors were genetics, olfactory dysfunction, dream enactment behavior, orthostatic intolerance, or hypotension; individuals who had ≥3 confirmed risk factors underwent CSF sampling and were followed for up to 7.5 years. Participants who developed a central LBD (LBD+) were compared to those who did not. Quadruplicate SSA areas under the curve (AUC) were averaged.
Results
Of 11 subjects with average AUCs above 500,000 units, 7 (64%) developed a central LBD compared to 1 of 20 (5%), with AUCs below the cutoff value ( P = 0.0011 by log‐rank test). Conversely, 7 of 8 (88%) LBD+ participants had elevated initial AUCs.
Conclusions
Increased CSF SSA predicts central LBDs. Individuals who develop a central LBD have elevated initial SSA AUCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Autonomic Medicine Section (AMS), Clinical Neurosciences Program (CNP), Division of Intramural Research (DIR), National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethes…
- TSE/Prion Biochemistry Section, DIR, National Institute of Allergy and Infectious Diseases (NIAID), Hamilton, Montana, USA.
ORCID-Profile: David S Goldstein
Förderung
- NINDS NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Goldstein, D. S., Alam, P., Sullivan, P., Holmes, C., Gelsomino, J., Hughson, A. G., & Caughey, B. (2025). Elevated Cerebrospinal Fluid α‐Synuclein Seeding Activity Predicts Central Lewy Body Diseases. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.14333
Vancouver
Goldstein DS, Alam P, Sullivan P, Holmes C, Gelsomino J, Hughson AG, et al. Elevated Cerebrospinal Fluid α‐Synuclein Seeding Activity Predicts Central Lewy Body Diseases. Movement Disorders Clinical Practice. 2025. doi:10.1002/mdc3.14333
BibTeX
@article{Goldstein2025,
author = {Goldstein, David S and Alam, Parvez and Sullivan, Patti and Holmes, Courtney and Gelsomino, Janna and Hughson, Andrew G and Caughey, Byron},
title = {Elevated Cerebrospinal Fluid α‐Synuclein Seeding Activity Predicts Central Lewy Body Diseases},
journal = {Movement Disorders Clinical Practice},
year = {2025},
doi = {10.1002/mdc3.14333}
}
EUVIMED